Versant Stock Surges on Q1 Results Highlighting Licensing and Platform Strength Allogene Therapeutics Inc ALLO Q1 2026 Earnings Narrower Loss Surprises Analysts as Cell Therapy Pipeline Advances Supreme Court Criticizes NTAs Adhocism in NEET Paper Leak Ruling Education Sector Faces Scrutiny